• Multiomics Used To Stratify Multiple Myeloma Patients Into Affinity Groups

    Clinical Research News | All new multiple myeloma patients being treated at the Tisch Cancer Institute at Mount Sinai are now being assigned to one of 12 subgroups based on shared genetic and molecular features of their disease. The multiple myeloma patient similarity network (MM-PSN) is one of the latest computational modeling tools being used here to translate clinical data into better treatment decision-making in the clinic, and the first to apply multiomics to the stratification of patients with the blood cancer.

    Jan 6, 2022

  • Balancing Convenience And Engagement In Decentralized Clinical Trials

    Clinical Research News | Decentralized clinical trials (DCTs) are a valued option for many would-be study participants as well as a chance to customize the research experience and cater to their needs, according to Ken Getz, founder and chair of the Center for Information & Study on Clinical Research Participation (CISCRP). Findings of CISCRP’s 2021 Perceptions and Insights study indicate interest in DCT approaches is quite high provided they don’t interfere with the quality of patients’ personal relationship with study staff.

    Jan 4, 2022

  • Follow the Money: Blood Collection Tech, SPR-Based Proteomics, AAV Gene Therapy Vectors, More

    Clinical Research News | Technologies for blood collection and testing, immune-competent organoids, flow cytometry for cell therapies, and SPR-based proteomics; funding for Brown Cancer Center

    Dec 28, 2021

  • Top Stories of 2021: COVID-19 Vaccines, Decentralized Trials, External Control Arms, Increased Diversity, AI

    Clinical Research News | Businesses everywhere also looked to leverage the COVID-associated disruptions to the benefit of themselves and society—with new technology to enable and facilitate decentralized clinical trials, arguments for the increased acceptance of external control arms, and the place of AI in clinical data. We also explored practical ideas for increasing clinical trial diversity and reported on a new initiative for better data sharing and standardization in the realm of rare diseases.

    Dec 27, 2021

  • Equipping Your Cold Chain Infrastructure for Decentralized Clinical Trials

    Clinical Research News | Decentralized clinical trials (DCTs) mitigate the burden of transportation, lodging, meals, and dependent care that often pose barriers to study participants. Still, the adoption of DCTs requires a fundamental shift in infrastructure to maintain compliance. This not only includes a shift to the cloud for virtual collaboration between stakeholders and data sharing, but also the elements of infrastructure that cannot be virtualized, such as the cold chain.

    Dec 23, 2021

  • ArisGlobal’s FDA Rollout, Science 37 in China, Russia, More

    Clinical Research News | ArisGlobal announces FDA go-live for adverse event reporting, Metabolon plans collaborations with Boston hospitals for lactation research, THREAD names Amazon-alum to Chief Product Officer role, and Science 37 expands to China and Russia. Plus new products from Certara, Leica Microsystems, and more.

    Dec 22, 2021

  • Recognize, Recall & Refine: Eliminating Bias in Computer Vision

    Clinical Research News | More and more, we’re seeing AI’s ability to transform drug development. It plays an increasing role in evaluating how patients respond to treatment during a clinical trial and helping to extract meaningful insights that can improve drug development and bring drugs to market faster. But, the power of AI lies in the quality and quantity of its data backbone, so consistently evaluating that data to ensure it is representative of all patient populations is crucial to its success.

    Dec 17, 2021

  • Seven Bridges Launches the Unified Patient Network With Genomic, EHR Data

    Clinical Research News | Seven Bridges Genomics has launched a new subsidiary, the Unified Patient Network (UPN), to facilitate clinical research and collaboration between participating health systems and biopharma companies. The UPN will combine de-identified sequencing data and EHR content for five million patients and allow biopharma companies to license cohorts from that dataset for research. Licensing fees from biopharma will fund the network.

    Dec 13, 2021